Detalhe da pesquisa
1.
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance.
Nature
; 494(7436): 251-5, 2013 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-23302800
2.
Chemoproteomics reveals immunogenic and tumor-associated cell surface substrates of ectokinase CK2α.
bioRxiv
; 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562834
3.
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
bioRxiv
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463958
4.
Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins.
Nat Biotechnol
; 41(2): 273-281, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138170
5.
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies.
J Immunother Cancer
; 11(11)2023 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38007238
6.
Structural surfaceomics reveals an AML-specific conformation of integrin ß2 as a CAR T cellular therapy target.
Nat Cancer
; 4(11): 1592-1609, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37904046
7.
Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
Biochem Pharmacol
; 73(1): 44-55, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17046720
8.
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
Nat Med
; 21(11): 1318-25, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479923